Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Rang in Aktien #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Aktienkurs
$0.60736143
Marktkapitalisierung
$58.28M
Veränderung (1 Tag)
-1.04%
Veränderung (1 Jahr)
-21.09%
Land
TW
Handel Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategorie

Aktien-Split-Historie für Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Die Aktie Gwo Xi Stem Cell Applied Technology Co. , Ltd (Symbol: 6704) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 21, 2026 statt.
Eine 6704-Aktie, die vor dem Aug 21, 2026 gekauft wurde, entspricht heute 0 6704-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH